The Department of Veterans Affairs (VA) awarded an indefinite-delivery/indefinite-quantity (IDIQ) contract to Foundation Medicine, Inc., a foreign-owned for-profit organization, for genomic sequencing testing services. The potential contract value exceeds $111 million and does not utilize any set-aside designations.
Under this IDIQ contract, Foundation Medicine has been awarded multiple firm fixed price delivery orders to provide a range of genomic sequencing, next-generation sequencing (NGS), hematologic malignancies testing, and other molecular diagnostic services to support the VA's precision oncology and healthcare programs for veterans. The contract work is primarily performed at Foundation Medicine's facilities in Massachusetts, North Carolina, Virginia, and other locations. The VA Headquarters and various Veterans Integrated Service Networks have issued these delivery orders, which generally range from $0 to over $24 million in potential value and have completion dates through 2024. This IDIQ contract and associated delivery orders enable the VA to efficiently obtain specialized genomic testing and analysis capabilities to enhance personalized medicine approaches for veterans.
Generated 4/25/24, 6:24 PM